The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The growing incidence of type 2 diabetes is a major problem [1] and may be associated with a variety of lipid abnormalities that pose cardiovascular disease risk factors, including hypertriacylglycerolaemia, increased levels of small dense LDL and low levels of HDL [2].”
BackgroundThe biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Self-citationInsulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963 · cited 1×
“GLP-1 slows gastric emptying and induces anorectic effects [9], while GIP has anabolic effects on adipose tissue [10] and regulates adipokine secretion [11].”
BackgroundAschner, P., Kipnes, M. S., Lunceford, J. K., Sanchez, M., Mickel, C., Williams-Herman, D. E., & for the Sitagliptin Study 021 Group (2006) · Diabetes Care · doi:10.2337/dc06-0703 · Cited by 880
Nauck, M. A., Meininger, G., Sheng, D., Terranella, L., Stein, P. P., & Sitagliptin Study 024 Group (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00704.x · Cited by 667
Raz, I., Hanefeld, M., Xu, L., Caria, C., Williams-Herman, D., Khatami, H., & Sitagliptin Study 023 Group (2006) · Diabetologia · doi:10.1007/s00125-006-0416-z · Cited by 614 · cited 1×
“DPP-4 inhibition lowers fasting and postprandial glycaemia in patients with type 2 diabetes mellitus [13, 14]; hence there is considerable interest in understanding the effects of incretins and DPP-4 inhibitors on plasma lipid profiles [15].”
BackgroundBaggio, L. L., Huang, Q., Brown, T. J., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2492 · Cited by 386
Self-citationBaggio, L. L., Huang, Q., Brown, T. J., & Drucker, D. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.063 · Cited by 372 · cited 1×
“GLP-1 slows gastric emptying and induces anorectic effects [9], while GIP has anabolic effects on adipose tissue [10] and regulates adipokine secretion [11].”
BackgroundSelf-citationMechanisms of Hepatic Very Low Density Lipoprotein Overproduction in Insulin Resistance
Taghibiglou, C., Carpentier, A., Van Iderstine, S. C., Chen, B., Rudy, D., Aiton, A., Lewis, G. F., & Adeli, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8416 · Cited by 347
Self-citationMatikainen, N., Mänttäri, S., Schweizer, A., Ulvestad, A., Mills, D., Dunning, B. E., Foley, J. E., & Taskinen, M.-R. (2006) · Diabetologia · doi:10.1007/s00125-006-0340-2 · Cited by 336
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
Hansotia, T., Maida, A., Flock, G., Yamada, Y., Tsukiyama, K., Seino, Y., & Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci25483 · Cited by 290
Self-citationMeier, J. J., Gethmann, A., Götze, O., Gallwitz, B., Holst, J. J., Schmidt, W. E., & Nauck, M. A. (2006) · Diabetologia · doi:10.1007/s00125-005-0126-y · Cited by 276 · cited 3×
“Moreover, GLP-1 administration reduced postprandial circulating lipid levels in human participants [18], although the underlying mechanisms remain uncertain.”
BackgroundThe Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting
Longuet, C., Sinclair, E. M., Maida, A., Baggio, L. L., Maziarz, M., Charron, M. J., & Drucker, D. J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.008 · Cited by 272
Self-citationHaidari, M., Leung, N., Mahbub, F., Uffelman, K. D., Kohen-Avramoglu, R., Lewis, G. F., & Adeli, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200544200 · Cited by 269
Self-citationBergman, A. J., Stevens, C., Zhou, Y., Yi, B., Laethem, M., De Smet, M., Snyder, K., Hilliard, D., Tanaka, W., Zeng, W., et al. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.01.015 · Cited by 265
Taghibiglou, C., Rashid-Kolvear, F., Van Iderstine, S. C., Le-Tien, H., Fantus, I. G., Lewis, G. F., & Adeli, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106737200 · Cited by 236
Self-citationActivation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609088200 · Cited by 216 · cited 1×
“Acute administration of GIP reduces circulating chylomicrons, probably by promoting triacylglycerol catabolism by adipose tissue [16, 17]; GLP-1 also attenuates postprandial triacylglycerol secretion [18, 19], although the exact underlying mechanisms are not clear.”
BackgroundGLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats
Qin, X., Shen, H., Liu, M., Yang, Q., Zheng, S., Sabo, M., D’Alessio, D. A., & Tso, P. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00303.2004 · Cited by 160
Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs.
Wasada, T., McCorkle, K., Harris, V., Kawai, K., Howard, B. V., & Unger, R. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110335 · Cited by 157
Federico, L. M., Naples, M., Taylor, D., & Adeli, K. (2006) · Diabetes · doi:10.2337/db04-1084 · Cited by 153
Self-citationSchaefer, E. J., McNamara, J. R., Shah, P. K., Nakajima, K., Cupples, L. A., Ordovás, J. M., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.989 · Cited by 148
Iakoubov, R., Izzo, A. A., Yeung, A., Whiteside, C. I., & Brubaker, P. L. (2006) · Endocrinology · doi:10.1210/en.2006-1403 · Cited by 114
Boschmann, M., Engeli, S., Dobberstein, K., Budziarek, P., Strauss, A., Boehnke, J., Sweep, F. C. G. J., Luft, F. C., He, Y., Foley, J. E., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1400 · Cited by 112
Incretins and the development of type 2 diabetes
Meier, J. J., & Nauck, M. A. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0034-7 · Cited by 105
Relationship between insulin-resistance and remnant-like particle cholesterol
Ohnishi, H., Saitoh, S., Takagi, S., Ohata, J., Isobe, T., Kikuchi, Y. S., Takeuchi, H., & Shimamoto, K. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00057-6 · Cited by 89
Cellular Aspects of Intestinal Lipoprotein Assembly in Psammomys Obesus
Zoltowska, M., Ziv, E., DELVIN, E. E., Sinnett, D., Kalman, R., Garofalo, C., Seidman, E. G., & Levy, E. H. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2539 · Cited by 81
Ebert, R., Nauck, M. A., & Creutzfeldt, W. (1991) · Hormone and Metabolic Research · doi:10.1055/s-2007-1003745 · Cited by 80
Postprandial lipid metabolism in diabetes
Mero, N., Syvänne, M., & Taskinen, M. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00218-4 · Cited by 75
Levy, E. H., Sinnett, D., Thibault, L., Nguyen, T. D., DELVIN, E. E., & Ménard, D. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00896-4 · Cited by 67
Lu, W. J., Yang, Q., Sun, W. Y., Woods, S. C., D’Alessio, D. A., & Tso, P. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2007 · Cited by 36
Efficacy and Safety of Incretin Therapy in Type 2 Diabetes: Systematic Review and Meta-analysis
Amori, R. E., Lau, J., & Pittas, A. G. (2007) · JAMA · doi:10.1001/jama.298.2.194 · Cited by 12
Lövestam-Adrian (1997) · Research Portal (Queen's University Belfast) · doi:10.1002/(sici)1096-9136(199712)14:12 · Cited by 4
Cited by
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170
“GLP-1 also inhibits postprandial chylomicron secretion and lowers circulating triglyceride levels in rodents and humans (Hsieh et al., 2010; Xiao et al., 2012); however, neither enterocytes nor hepatocytes express the canonical GLP-1R (Panjwani et al., 2013; Pyke et al., 2014; Richards et al.,…”
BackgroundSelf-citationTriglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
Incretin hormones: Their role in health and disease
Nauck, M. A., & Meier, J. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13129 · Cited by 950
The Cardiovascular Biology of Glucagon-like Peptide-1
Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.009 · Cited by 665
Self-citation
Metadata
- Authors
- Hsieh, J., Longuet, C., Baker, C. L., Qin, B., Federico, L. M., Drucker, D. J., & Adeli, K.
- Venue
- Diabetologia
- Published
- 2009-12-03
- Volume
- 53
- Issue
- 3
- Pages
- 552-561
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2086985270
- Cited by
- 275
- References
- 33
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.